Axios
Makary's exit creates new uncertainty at FDA
Marty Makary's departure from the Food and Drug Administration may remove one of the Trump administration's lightning rods for controversy. But it won't solve the organizational upheaval and political jockeying that marked much of his 13-month tenure. Why it matters: There's lots of uncertainty around how the Senate will find the bandwidth to confirm another FDA commissioner while it considers P
A
Source
Axios
Read full article at Axios
Opens original article in a new tab
Advertisement
